DCGI asked to stop over-the-counter sale of nicotine gums by the Delhi government

  • News
  • December 24, 2017

The Delhi government’s health department sent written request to the Drug Controller General of India (DGCI) to stop the over-the-counter sale of nicotine gums and lozenges without an authorized prescription. Dr. SK Arora in a letter addressing Dr. GN Singh, additional director (Health) said nicotine have potential addiction property and people can use like a drug in the form of gums and lozenges which were being sold at medical shops over the counter without any prescription.

During counseling, motivation and behavioral therapy, People addicted to a small percentage of moderate tobacco users may require these drugs as nicotine replacement therapy (NRT) under the supervision of qualified counsellors. But the selling of these drugs over the counter without any prescription promotes malpractices and self-therapy, it may lead to merely shifting the person from one addiction to another, the letter read.

Dr. Arora said the youngsters who can’t use tobacco products directly due to social or family fear may easily use them, s they should stop selling over counters.

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’